Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory

· 2023-07-13

Twelve high-risk alpha human papillomavirus (HPV) genotypes cause approximately 690,000 cancer cases annually, with cervical and oropharyngeal cancer being the two most prominent types. HPV testing is performed in laboratory settings for various applications of a clinical, epidemiological, and research nature using a range of clinical specimens collected by clinicians or by individuals (self-collected specimens).

Funding

European Commission

847845

EC | European Research Council

101040588